READ THE EVIDENCE, NOT THE HYPE.
SCIENCE
LIBRARY.
This educational library separates human clinical evidence from animal, cellular, and mechanistic research so readers can see what was studied, what remains unanswered, and where claims exceed the evidence.
Controlled or observational research involving people.
Animal or cell research—not proof of a human outcome.
Explains a biological pathway, not a demonstrated benefit.
TRIPLE-RECEPTOR
RESEARCH
Retatrutide is a single investigational molecule designed to activate three nutrient-responsive hormone receptors: GIP, GLP-1, and glucagon.
Explore RETA science →Glucose-dependent insulinotropic polypeptide
Studied for its role in nutrient signaling and glucose-dependent insulin response.
Glucagon-like peptide-1
Studied in appetite signaling, gastric emptying, and glucose-dependent insulin secretion.
Glucagon receptor
Studied for roles in hepatic energy metabolism and energy expenditure.
THREE RESEARCH
PATHWAYS
The GLOW educational profile maps the separate evidence for GHK-Cu, BPC-157, and thymosin β4-related research. It does not establish the safety or effectiveness of a combined formulation.
Explore the GLOW evidence map →GHK-Cu
Studied in cellular signaling, collagen-related pathways, inflammation, and tissue repair models.
BPC-157
Most published findings are animal studies. Reviews find major gaps in human safety, dosing, and efficacy data.
TB-500 / Thymosin β4 research
Thymosin β4 has been studied in cell and animal models of migration, angiogenesis, and wound repair. TB-500 products are not established human therapies.